phenobarbital 30mg tablets
bristol laboratories ltd - phenobarbital - oral tablet - 30mg
phenobarbital 60mg tablets
bristol laboratories ltd - phenobarbital - oral tablet - 60mg
phenobarbital tablet
aphena pharma solutions - tennessee, inc. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 32.4 mg - - sedative - anticonvulsant – for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. controlled substance – phenobarbital is a schedule iv drug. dependence – barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the same level of intox
phenobarbital sodium injection
hikma pharmaceuticals usa inc. - phenobarbital sodium (unii: sw9m9bb5k3) (phenobarbital - unii:yqe403bp4d) - phenobarbital sodium 65 mg in 1 ml - - sedative. sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety-tension states, hyperthyroidism, essential hypertension, nausea and vomiting of functional origin, motion sickness, acute labyrinthitis, pylorospasm in infants, chorea and cardiac failure. phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract. phenobarbital controls anxiety, decreases muscular activity and lessens nervous excitability in hyperthyroid patients. however, thyrotoxic individuals occasionally react poorly to barbiturates. - hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see clinical pharmacology ). - preanesthetic. - long-term anticonvulsant, (phenobarbital, mephobarbital and metharbital) for the treatme
phenobarbital 15mg tablets
a a h pharmaceuticals ltd - phenobarbital - oral tablet - 15mg
phenobarbital 15mg tablets
teva uk ltd - phenobarbital - oral tablet - 15mg
phenobarbital 15mg tablets
the boots company plc - phenobarbital - oral tablet - 15mg
phenobarbital 15mg tablets
kent pharma (uk) ltd - phenobarbital - oral tablet - 15mg
phenobarbital 15mg tablets
alliance healthcare (distribution) ltd - phenobarbital - oral tablet - 15mg
phenobarbital 15mg tablets
dowelhurst ltd - phenobarbital - oral tablet - 15mg